Key facts
- This page summarizes Neena M. Patil's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 20 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2026, 17:06.
Neena M. Patil - 26 Feb 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- EVP & Chief Legal Officer
- Issuer ticker
- JAZZ
- Reported as of
- 26 Feb 2026
- Net transaction value
- -$4,161,782
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2026, 17:06:54 UTC
- Prior SEC filing
- 21 Jan 2026
- Next SEC filing
- 09 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Neena Patil
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Neena M. Patil filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Mar 2026.
Change
- Previous filing in this sequence was filed on 21 Jan 2026.
- Current net transaction value: -$4,161,782.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001783908
Primary reporting owner
Patil Neena M
- Relationship
- EVP & Chief Legal Officer
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Neena Patil
- Signature date
- 02 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $2,276,138
- Shares
- +20,125
- Change %
- +38%
- Price
- $113.10
- Shares after
- 73,464
- Date
- 26 Feb 2026
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $3,196,335
- Shares
- -16,602
- Change %
- -23%
- Price
- $192.53
- Shares after
- 56,862
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $98,962
- Shares
- +875
- Change %
- +1.5%
- Price
- $113.10
- Shares after
- 57,737
- Date
- 26 Feb 2026
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $168,057
- Shares
- -875
- Change %
- -1.5%
- Price
- $192.07
- Shares after
- 56,862
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $3,713,758
- Shares
- +27,084
- Change %
- +48%
- Price
- $137.12
- Shares after
- 83,946
- Date
- 26 Feb 2026
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $2,959,807
- Shares
- -15,555
- Change %
- -19%
- Price
- $190.28
- Shares after
- 68,391
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F3
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $399,842
- Shares
- +2,916
- Change %
- +4.3%
- Price
- $137.12
- Shares after
- 71,307
- Date
- 26 Feb 2026
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $553,491
- Shares
- -2,916
- Change %
- -4.1%
- Price
- $189.81
- Shares after
- 68,391
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F4
JAZZ
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +10,079
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 78,470
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F5
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $2,209,481
- Shares
- -11,529
- Change %
- -15%
- Price
- $191.65
- Shares after
- 66,941
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F6
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $681,993
- Shares
- -3,523
- Change %
- -5.3%
- Price
- $193.58
- Shares after
- 63,418
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F7
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $201,594
- Shares
- -1,061
- Change %
- -1.7%
- Price
- $190.00
- Shares after
- 62,357
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F8
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $104,747
- Shares
- -549
- Change %
- -0.88%
- Price
- $190.80
- Shares after
- 61,808
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F9
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $342,312
- Shares
- -1,784
- Change %
- -2.9%
- Price
- $191.88
- Shares after
- 60,024
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F10
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $194,527
- Shares
- -1,009
- Change %
- -1.7%
- Price
- $192.79
- Shares after
- 59,015
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F11
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $38,139
- Shares
- -197
- Change %
- -0.33%
- Price
- $193.60
- Shares after
- 58,818
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F12
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JAZZ
transaction
Derivative
Incentive Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -875
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 875
- Exercise price
- $113.10
- Footnotes
- F13
JAZZ
transaction
Derivative
Incentive Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,916
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,916
- Exercise price
- $137.12
- Footnotes
- F14
JAZZ
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,125
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 20,125
- Exercise price
- $113.10
- Footnotes
- F13
JAZZ
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -27,084
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 27,084
- Exercise price
- $137.12
- Footnotes
- F14
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 14 footnotes
Footnote F1
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.1100 to $193.0100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.0600 to $192.1100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F3
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.9150 to $190.9000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F4
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $189.7300 to $189.9150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F5
These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
Footnote F6
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.3200 to $192.0600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F7
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.2900 to $193.8400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F8
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.395 to $190.3700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F9
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.4100 to $191.2150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F10
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.4750 to $192.4300. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F11
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $192.4600 to $193.4500. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F12
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $193.5300 to $193.6700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F13
These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
Footnote F14
These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of July 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.